mechanism of action of glp-1 receptor agonists Glucagon-like peptide 1 agonists: cardiovascular benefits and mechanisms GLP-1 Receptor Agonists Explained for

Our findings suggest that GLP-1 medications could potentially have a dual benefit for patients, not only in managing their diabetes or obesity but also in potentially reducing the likelihood of depression and anxiety diagnoses, Kersten Bartelt, RN, a clinician at Epic Research, told Healio

The medication may trigger systemic inflammation, affecting the ocular surface and contributing to dry eye symptoms

Can J Biochem 49(8):867872 Brown J, Dryburgh J, Ross S, Dupre J (1975) Identification and actions of gastric inhibitory polypeptide

It may compromise weight control where patients are taking GLP-1RAs and GLP-1/GIPRAs for this indication

Orforglipron (LY3502970), a novel, oral non-peptide glucagon-like peptide-1 receptor agonist: A Phase 1b, multicentre, blinded, placebo-controlled, randomized, multiple-ascending-dose study in people with type 2 diabetes

Some women may feel guilty if they opt to restart their GLP-1 over breastfeeding, but keep in mind that ensuring your own long-term health will only benefit your child in the long run